✦ LIBER ✦

PEG-interfeoon α-2b + ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b + ribavirin therapy

✍ Scribed by Sulkowski, Mark; Rothstein, Ken; Stein, Lawrence; Godofsky, Elliot; Goodman, Russell; Dieterich, Douglas

Book ID: 123055519
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 170 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83956-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination treatment with interferon al

Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis c in patients who have failed interferon therapy

✍ Birdi, Parvinder K.; Wustrack, Sonja; Rostetter, Elizabeth; King, John W.; Balar 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

PG18 A COST-EFFECTIVENESS EVALUATION—RET

PG18 A COST-EFFECTIVENESS EVALUATION—RETREATMENT WITH PEGYLATED INTERFERON ALFA 2B PLUS RIBAVIRIN IN HEPATITIS C PATIENTSWHO HAVE PREVIOUSLY RECEIVED INTERFERON-BASED THERAPY AND FAILED TO ATTAIN A SUSTAINED VIROLOGICAL RESPONSE

✍ CJ Gibbons; J Morris; AK O'Sullivan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Ribavirin/interferon alpha-2b therapy is

Ribavirin/interferon alpha-2b therapy is very effective in the treatment of chronic hepatitis C genotype 2 & 3 patients who have failed to respond virologically to interferon monotherapy

✍ Neville Pimstone; Paul Sheykhzadeh; John Canio; Michelle Chiang; Jerry Powell; J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Homocysteine levels and sustained virolo

Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study

✍ Guglielmo Borgia; Ivan Gentile; Giuliana Fortunato; Francesco Borrelli; Salvator 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Ribavirin/interferon α-2b (IFN) therapy

Ribavirin/interferon α-2b (IFN) therapy is very effective in the treatment of chronic hepatitis C genotype 2&3 patients who have failed to respond virologically to IFN monotherapy

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of